Clinical Trial Update: A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America

View source ↗

Summary

This Clinical Trial Update reports that niraparib is being evaluated under an Expanded Access Program for ovarian cancer in Latin America, sponsored by the Lati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Ovarian Cancer | Status: ACTIVE_NOT_RECRUITING